Receptors and lipid transfer proteins in HDL metabolism

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 103-112

  Silver, David L ^a   Jiang, Xian Cheng ^a   Arai, Takeshi ^a   Bruce, Can ^a   Tall, Alan R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTOR; LIPID TRANSFER PROTEIN;

ATHEROSCLEROSIS; CATABOLISM; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MOUSE; NONHUMAN; OBESITY;

EID: 0034043085     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06305.x     Document Type: Conference Paper

References (40)

1. 1. BRESLOW, J. 1994. Curr. Opin. Lipidol. 5: 175-184.
2. 2. MILLER, N. 1980. In Atherosclerosis: 500-503. Springer Publishing Co. New York.
3. 3. FIDGE, N. P. NESTEL, T. ISHIKAWA, M. REARDON & T. BILLINGTON. 1980. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism 29: 643-653.
4. 4. TALL, A.R. & J.L. BRESLOW. 1996. In Atherosclerosis and Coronary Artery Disease: 105-128. Lippincott-Raven. Philadelphia.
5. 5. HOROWITZ, B.S. et al. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subject with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91: 1743-1752.
6. 6. BRINTON, E.A., S. EISENBERG & J.L. BRESLOW. 19994. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein Lipases, triglyceride and insulin level, and body fat distribution. Arterioscler. Thromb. 14: 707-720.
7. 7. MEHRABIAN, M. et al. 1993. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. [Erratum published in Arterioscler. Thromb. 1993. 13: 466] Arterioscler. Thromb. 13: 1-10.
8. 8. TALL, A.R. 1998. An overview of reverse cholesterol transport. Eur. Heart J. 19(Suppl A): A31-A35.
9. 9. FIDGE, A.H. 1999. High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40: 187-201.
10. 10. RIGOTTI, A. et al. 1997. Scavenger receptor BI - a cell surface receptor for high density lipoprotein. Curr. Opin. Lipidol. 8: 181-188.
11. 11. ACTON, S. et al. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [see Comments]. Science 271: 518-520.
12. 12. VARBAN, M.L. et al. 1998. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol [see Comments]. Proc. Natl. Acad. Sci. USA 95: 4619-4624.
13. 13. RIGOTTI, A. et al. 1997. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA 94: 12610-12615.
14. 14. BROWN, M.S, J. HERZ & J.L. GOLDSTEIN. 1997. LDL-receptor structure. Calcium cages, acid baths and recycling receptors [news; comment]. Nature 388: 629-630.
15. 15. NISHINA, P.M., S. LOWE, J. WANG & B. PAIGEN. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43: 549-553.
16. 16. HAMANN, A., J.S. FLIER & B.B. LOWELL. 1998. Obesity after genetic ablation of brown adipose tissue. Z. Ernahrungswiss. 37: 1-7.
17. 17. ZHANG, Y. et al. 1994. Positional cloning of the mouse obese gene and its human homologue. [Erratum published in Nature. 1995. 374: 479] [See Comments]. Nature 372: 425-432.
18. 18. LEE, G.H. et al. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
19. 19. SILVER, D.L., X.C. JIANG & A.R. TALL. 1999. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J. Biol. Chem. 274: 4140-4146.
20. 20. GUEUNDOUZI, K., X. COLLET, B. PERRET, H. CHAP & R. BARBARAS. 1998. Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2). Biochemistry 37: 14974-14980.
21. 21. TAMAI, T., W. PATSCH, D. LOCK & G. SCHONFELD. 1983. Receptors for homologous plasma lipoproteins on a rat hepatoma cell line. J. Lipid Res. 24: 1568-1577.
22. 22. KAMBOURIS, A.M., P.D. ROACH, G.D. CALVERT & P.J. NESTEL. 1990. Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2. Arteriosclerosis 10: 582-590.
23. 23. DELAMATRE, J.G., T.G. SARPHIE, R.C. ARCHIBOLD & C.A. HORNICK. 1990. Metabolism of apoE-free high density lipoproteins in rat hepatoma cells: evidence for a retroendocytic pathway. J. Lipid Res. 31: 191-202.
24. 24. TAKATA, K., S. HORIUCHI, A.T. RAHIM & Y. MORINO. 1988. Receptor-mediated internalization of high density lipoprotein by rat sinusoidal liver cells: identification of a nonlysosomal endocytic pathway by fluorescence-labeled ligand. J. Lipid Res. 29: 1117-1126.
25. 25. TALL, A.R. & P.H. GREEN. 1981. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J. Biol. Chem. 256: 2035-2044.
26. 26. MJOS, O.D., O. FAERGEMAN, R.L. HAMILTON & R.J. HAVEL. 1975. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. J. Clin. Invest. 56: 603-615.
27. 27. BEAMER, L.J., S.F. CARROLL & D. EISENBERG. 1997. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276: 1861-1864.
28. 28. JIANG, X. et al. 1996. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J. Clin. Invest. 98: 2373-2380.
29. 29. EHNHOLM, S. et al. 1998. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39: 1248-1253.
30. 30. LUSA, S., M. JAUHIAINEN, J. METSO, P. SOMERHARJU & C. EHNHOLM. 1996. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem. J. 313: 275-282.
31. 31. WILLIAMS, K.J., A.R. TALL, C. BISGAIER & R. BROCIA. 1987. Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. J. Clin. Invest. 79: 1466-1472.
32. 32. BERGERON, N. et al. 1998. Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase. Proc. Natl. Acad. Sci. USA 95: 15647-15652.
33. 33. KOZARSKY, K.F. et al. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387: 414-417.
34. 34. WANG, N., T. ARAI, Y. JI, F. RINNINGER & A.R. TALL. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926.
35. 35. JI, Y. et al. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
36. 36. ARAI, T., N. WANG, M. BEZOUEVSKI, C. WELCH & A.R. TALL. 1999. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274: 2366-2371.
37. 37. ACTON, S.L., P.E. SCHERER, H.F. LODISH & M. KRIEGER. 1994. Expression cloning of SR-BI a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009.
38. 38. VENIANT, M.M. et al. 1997. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 and apolipoprotein B100. J. Clin. Invest. 100: 180-188.
39. 39. MAROTTI, K.R. et al. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364: 73-75.
40. 40. LI, H., R.L. REDDICK & N. MAEDA. 1993. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler. Thromb. 13: 1814-1821.